NSE filing, NSE: HDFCBANK. Summary written from the filing by ALFA Finder's alert engine.
HDFC Bank Ltd: key numbers
- Share price
- ₹685.30
- Market cap
- ₹10,57,263 Cr
- Revenue (annual)
- ₹3,48,615 Cr
- Net profit (annual)
- ₹76,026 Cr
- P/E (TTM)
- 13.2×Sector 19.7×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 39.39%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from HDFC Bank Ltd
All →HDFC Bank Management Change
HDFC Bank confirmed that Anup Bagchi assumed charge as MD & CEO effective October 27, 2026, succeeding Sashidhar Jagdishan. The filing also lists the bank's updated KMP contact details.
HDFC Bank Debt & Borrowing: ₹483 Cr
HDFC Bank confirmed the payment of ₹483 Crore interest on its debt securities (ISIN INE040A08AC9) for the due date of October 22, 2026.
- Value
- ₹483.0 Cr
HDFC Bank Employee Stock Options
HDFC Bank allotted 91,38,522 equity shares to employees upon ESOP/RSU exercise. Paid-up capital rose to 15,42,77,35,870 shares of ₹1 each.
HDFC Bank Annual General Meeting
HDFC Bank issued a postal ballot to re-appoint Mrs. Lily Vadera as Independent Director for three years. E-voting: October 22 to November 20, 2026.
HDFC Bank Earnings Call Transcript: Key Takeaways
Management focused on a strategic pivot toward customer service efficiency and digital adoption to drive growth while navigating current liquidity constraints.
HDFC Bank Management Change
HDFC Bank announced the re-appointment of Mrs. Lily Vadera as Independent Director and the upcoming cessation of service of Mr. Kaizad Bharucha, Deputy Managing Director.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date